Showing 22,152 results

Filters Content type: Editors' picks
People who inject drugs

329 NGOs call on world leaders to address the global health and human rights crisis among people who use drugs on the occasion of the 26th International Harm Reduction Conference

Editor's pick
International Drug Policy Consortium
1 May 2019
People & personal stories

‘There was no future’: victims share impact of infected blood scandal

Editor's pick
The Guardian
1 May 2019
Elimination of hepatitis C

NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

Editor's pick
pharmaphorum
30 April 2019
Elimination of hepatitis C

NHS England strikes world leading deal to help eliminate hepatitis C

Editor's pick
NHS England
30 April 2019
Drug interactions & pharmacokinetics

Do Feminizing Hormones Impact Efficacy of PrEP Drugs?

Editor's pick
Contagion Live
29 April 2019
Young people

PrEP vs. Privacy

Editor's pick
Slate
29 April 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine

Editor's pick
ViiV press release
29 April 2019
Drug policy & policing

People Before Politics: 4 Key Points in HR19’s Opening Ceremony

Editor's pick
Talking Drugs
29 April 2019
PrEP policies & guidelines

The Irish Times view on PrEP and HIV: A matter of urgency

Editor's pick
Irish Times
29 April 2019
Improving HIV care

In Ethiopia, A Focus on Multi-Month ART Scripting at Scale Pays Off

Editor's pick
ICAP
26 April 2019
Combatting stigma

Rep. Brian Sims on Taking HIV Prevention Drug: 'The Shaming Around PrEP Is Akin to Shaming Women on the Pill'

Editor's pick
Newsweek
26 April 2019
Reproductive health

Barriers to sexual and reproductive health and rights among women living with HIV in Latin America and the Caribbean

Editor's pick
AVERT
26 April 2019
New & experimental HIV treatments

ViiV Healthcare announces CHMP Positive Opinion for Dovato® (dolutegravir/lamivudine) as a once-daily, single-pill, two-drug regimen for the treatment of HIV infection

Editor's pick
ViiV press release
26 April 2019
Young people

The Listening Project: I’ll Speak About it All Day Long (sound file)

Editor's pick
BBC
25 April 2019
Transgender people

The largest study involving transgender people is providing long-sought insights about their health

Editor's pick
Nature
25 April 2019
Telling people you have HIV

Challenging My Own Bigotry

Editor's pick
Poz
25 April 2019
Activism & civil society

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

Editor's pick
The Body
25 April 2019
HIV & criminal law

New Policy for British Columbia Prosecutors Still Harms People Living with HIV

Editor's pick
Canadian HIV/AIDS Legal Network
25 April 2019
Finding support

Africa: New Research Uses Online Search Data To Understand Public Health Needs

Editor's pick
Forbes
25 April 2019
Finance & funding

South Africa: Cutting U.S. funding will harm people with HIV most

Editor's pick
Health GAP
25 April 2019
People & personal stories

Ageing with HIV: Testimonials of Stigma and Discrimination in Healthcare Settings

Editor's pick
EATG
25 April 2019
Harm reduction

New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand

Editor's pick
Filter
25 April 2019
Pharmaceutical industry

US: The Justice Department Is Looking Into Gilead’s PrEP Profits

Editor's pick
Out
25 April 2019
Access to healthcare

HIV Medical Providers Strongly Oppose Proposed Changes To Medicare Drug Plan’s “Protected Classes”

Editor's pick
Poz
25 April 2019